Article Sidebar
Published:
Aug 9, 2005Keywords:
<i>Senna podocarpa</i> pods acute toxicity sub-chronic toxicity
Article Details
Section
Articles
Copyright: Creative Commons Attribution CC.
This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials. View License Deed | View Legal Code Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications.
Main Article Content
Toxicity potentials of Senna podocarpa (Guill.et Perr.) Lock pods in rodents
Abstract
The effects of acute (LD50) and sub-chronic doses of the aqueous infusion of Senna podocarpa (Guill. et Perr.) Lock pod on the liver, kidney, brain and testis of mice and rats were studied, respectively. The acute toxicity studies did not produce any observable lethal effects and the calculated LD50 was 6.6 g/kg. The histopathological analysis of the liver, kidney, brain and testis showed no adverse effect. Behavioral observations and the histopathological findings did not show significant differences between the control and the treated groups. There were no marked adverse alterations or degeneration of tissues since these vital organs showed normal architectures suggesting no morphological disturbances as compared with the control group. The findings indicated that the aqueous infusion of S. podocarpa pod was devoid of overt acute and sub-chronic toxic effects in mice and rats.
Key words: Senna podocarpa pods, acute toxicity, sub-chronic toxicity
Afr. J. Trad. Comp. Alt. Med. Vol.2(3) 2005: 274 - 281
Key words: Senna podocarpa pods, acute toxicity, sub-chronic toxicity
Afr. J. Trad. Comp. Alt. Med. Vol.2(3) 2005: 274 - 281
